B. TORAMAN Et Al. , "A novel Founder Mutation of CYP21A2 in Patients with CAH due to 21-Hydroxylase Deficiency," ESPE DUBLIN , Dublin, Ireland, pp.1-7, 2014
TORAMAN, B. Et Al. 2014. A novel Founder Mutation of CYP21A2 in Patients with CAH due to 21-Hydroxylase Deficiency. ESPE DUBLIN , (Dublin, Ireland), 1-7.
TORAMAN, B., KARAGÜZEL, G., KALAY, E., & DİNÇER, T., (2014). A novel Founder Mutation of CYP21A2 in Patients with CAH due to 21-Hydroxylase Deficiency . ESPE DUBLIN (pp.1-7). Dublin, Ireland
TORAMAN, BAYRAM Et Al. "A novel Founder Mutation of CYP21A2 in Patients with CAH due to 21-Hydroxylase Deficiency," ESPE DUBLIN, Dublin, Ireland, 2014
TORAMAN, BAYRAM Et Al. "A novel Founder Mutation of CYP21A2 in Patients with CAH due to 21-Hydroxylase Deficiency." ESPE DUBLIN , Dublin, Ireland, pp.1-7, 2014
TORAMAN, B. Et Al. (2014) . "A novel Founder Mutation of CYP21A2 in Patients with CAH due to 21-Hydroxylase Deficiency." ESPE DUBLIN , Dublin, Ireland, pp.1-7.
@conferencepaper{conferencepaper, author={BAYRAM TORAMAN Et Al. }, title={A novel Founder Mutation of CYP21A2 in Patients with CAH due to 21-Hydroxylase Deficiency}, congress name={ESPE DUBLIN}, city={Dublin}, country={Ireland}, year={2014}, pages={1-7} }